Skip to main content
Top
Published in: Rheumatology International 9/2014

01-09-2014 | Original Article

The relationship of neutrophil-to-lymphocyte ratio with gastrointestinal bleeding in Henoch–Schonlein purpura

Authors: Balahan Makay, Özge Altuğ Gücenmez, Murat Duman, Erbil Ünsal

Published in: Rheumatology International | Issue 9/2014

Login to get access

Abstract

Henoch–Schönlein purpura (HSP) is the most common systemic vasculitis of childhood. Gastrointestinal (GI) bleeding is one of the major complications of HSP. The blood neutrophil-to-lymphocyte ratio (NLR) is identified as a potentially useful marker of clinical outcome in inflammatory diseases. NLR may be a useful biomarker of GI bleeding in children with HSP, which has a neutrophil-dominated inflammation. The aim of this study was to evaluate NLR in patients with HSP and to investigate the relationship with GI bleeding. The study consisted of 63 HSP patients and 38 age- and sex-matched healthy children. C-reactive protein, white blood cell count, platelet count, mean platelet volume (MPV), hemoglobin level, and NLR were evaluated. Logistic regression analysis and receiver operating characteristic (ROC) analysis were used to determine the variables associated with GI bleeding. NLR and MPV were the only two indicators associated with GI bleeding in HSP in logistic regression analysis. The area under the ROC curve analysis indicated that NLR could be a more efficient potential predictor of GI bleeding in HSP when compared to MPV. This study suggested that higher NLR might predict GI bleeding in HSP.
Literature
2.
go back to reference Trapani S, Micheli A, Grisolia F, Resti M, Chiappini E, Falcini F, De Martino M (2005) Henoch–Schonlein purpura in childhood: epidemiological and clinical analysis of 150 cases over a 5-year period and review of literature. Semin Arthr Rheum 35:143–153CrossRef Trapani S, Micheli A, Grisolia F, Resti M, Chiappini E, Falcini F, De Martino M (2005) Henoch–Schonlein purpura in childhood: epidemiological and clinical analysis of 150 cases over a 5-year period and review of literature. Semin Arthr Rheum 35:143–153CrossRef
3.
go back to reference Ozen S, Bakkaloglu A, Dusunsel R, Soylemezoglu O, Ozaltin F, Poyrazoglu H, Kasapcopur O, Ozkaya O, Yalcinkaya F, Balat A, Kural N, Donmez O, Alpay H, Anarat A, Mir S, Gur-Guven A, Sonmez F, Gok F, Turkish Pediatric Vasculitis Study Group (2007) Childhood vasculitides in Turkey: a nationwide survey. Clin Rheumatol 26:196–200PubMed Ozen S, Bakkaloglu A, Dusunsel R, Soylemezoglu O, Ozaltin F, Poyrazoglu H, Kasapcopur O, Ozkaya O, Yalcinkaya F, Balat A, Kural N, Donmez O, Alpay H, Anarat A, Mir S, Gur-Guven A, Sonmez F, Gok F, Turkish Pediatric Vasculitis Study Group (2007) Childhood vasculitides in Turkey: a nationwide survey. Clin Rheumatol 26:196–200PubMed
4.
go back to reference Calvino MC, Llorca J, Garcia-Porrua C, Fernández-Iglesias JL, Rodriguez-Ledo P, González-Gay MA (2001) Henoch–Schonlein purpura in children from northwestern Spain. A 20–year epidemiologic and clinical study. Medicine 80:279–290CrossRefPubMed Calvino MC, Llorca J, Garcia-Porrua C, Fernández-Iglesias JL, Rodriguez-Ledo P, González-Gay MA (2001) Henoch–Schonlein purpura in children from northwestern Spain. A 20–year epidemiologic and clinical study. Medicine 80:279–290CrossRefPubMed
5.
go back to reference Saulsbury FT (1999) Henoch–Schonlein purpura in children. Report of 100 patients and review of the literature. Medicine 78:395–409CrossRefPubMed Saulsbury FT (1999) Henoch–Schonlein purpura in children. Report of 100 patients and review of the literature. Medicine 78:395–409CrossRefPubMed
6.
go back to reference Cull DL, Rosario V, Lally KP, Ratner I, Mahour GH (1990) Surgical implications of Henoch–Schonlein purpura. J Pediatr Surg 25:741–743CrossRefPubMed Cull DL, Rosario V, Lally KP, Ratner I, Mahour GH (1990) Surgical implications of Henoch–Schonlein purpura. J Pediatr Surg 25:741–743CrossRefPubMed
7.
go back to reference Lin SJ, Huang JL, Hsieh KH (1998) Clinical and laboratory correlation of acute Henoch–Schonlein purpura in children. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi 39:94–98PubMed Lin SJ, Huang JL, Hsieh KH (1998) Clinical and laboratory correlation of acute Henoch–Schonlein purpura in children. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi 39:94–98PubMed
8.
go back to reference Saulsbury FT, Kesler RW (1983) Thrombocytosis in Henoch–Schonlein purpura. Clin Pediatr 22:185–187CrossRef Saulsbury FT, Kesler RW (1983) Thrombocytosis in Henoch–Schonlein purpura. Clin Pediatr 22:185–187CrossRef
9.
go back to reference Makay B, Türkyilmaz Z, Duman M, Unsal E (2009) Mean platelet volume in Henoch–Schönlein purpura: relationship to gastrointestinal bleeding. Clin Rheumatol 28:1225–1228CrossRefPubMed Makay B, Türkyilmaz Z, Duman M, Unsal E (2009) Mean platelet volume in Henoch–Schönlein purpura: relationship to gastrointestinal bleeding. Clin Rheumatol 28:1225–1228CrossRefPubMed
11.
go back to reference Kim JY, Park T, Jeong SH, Jeong CY, Ju YT, Lee YJ, Hong SC, Ha WS, Choi SK, Jung EJ (2013) Prognostic importance of baseline neutrophil to lymphocyte ratio in patients with advanced papillary thyroid carcinomas. Endocrine. doi:10.1007/s12020-013-0089-6 Kim JY, Park T, Jeong SH, Jeong CY, Ju YT, Lee YJ, Hong SC, Ha WS, Choi SK, Jung EJ (2013) Prognostic importance of baseline neutrophil to lymphocyte ratio in patients with advanced papillary thyroid carcinomas. Endocrine. doi:10.​1007/​s12020-013-0089-6
12.
go back to reference Tamhane UU, Aneja S, Montgomery D, Rogers EK, Eagle KA, Gurm HS (2008) Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome. Am J Cardiol 102:653–657CrossRefPubMed Tamhane UU, Aneja S, Montgomery D, Rogers EK, Eagle KA, Gurm HS (2008) Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome. Am J Cardiol 102:653–657CrossRefPubMed
13.
go back to reference Nunez JE, Nunez E, Bodi V, Miñana G, Mainar L, Santas E, Merlos P, Rumiz E, Darmofal H, Heatta AM, Llàcer A (2008) Usefulness of the neutrophil to lymphocyte ratio in predicting long-term mortality in ST segment elevation myocardial infarction. Am J Cardiol 101:747–752CrossRefPubMed Nunez JE, Nunez E, Bodi V, Miñana G, Mainar L, Santas E, Merlos P, Rumiz E, Darmofal H, Heatta AM, Llàcer A (2008) Usefulness of the neutrophil to lymphocyte ratio in predicting long-term mortality in ST segment elevation myocardial infarction. Am J Cardiol 101:747–752CrossRefPubMed
14.
go back to reference Walsh SR, Cook EJ, Goulder F, Justin TA, Keeling NJ (2005) Neutrophil lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol 91:181–184CrossRefPubMed Walsh SR, Cook EJ, Goulder F, Justin TA, Keeling NJ (2005) Neutrophil lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol 91:181–184CrossRefPubMed
15.
go back to reference Uslu AU, Deveci K, Korkmaz S, Aydin B, Senel S, Sancakdar E, Sencan M (2013) Is neutrophil/lymphocyte ratio associated with subclinical inflammation and amyloidosis in patients with familial Mediterranean fever? Biomed Res Int. doi:10.1155/2013/185317 Uslu AU, Deveci K, Korkmaz S, Aydin B, Senel S, Sancakdar E, Sencan M (2013) Is neutrophil/lymphocyte ratio associated with subclinical inflammation and amyloidosis in patients with familial Mediterranean fever? Biomed Res Int. doi:10.​1155/​2013/​185317
16.
go back to reference Ozen S, Ruperto N, Dillon MJ, Bagga A, Barron K, Davin JC, Kawasaki T, Lindsley C, Petty RE, Prieur AM, Ravelli A, Woo P (2006) EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis 65:936–941CrossRefPubMedPubMedCentral Ozen S, Ruperto N, Dillon MJ, Bagga A, Barron K, Davin JC, Kawasaki T, Lindsley C, Petty RE, Prieur AM, Ravelli A, Woo P (2006) EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis 65:936–941CrossRefPubMedPubMedCentral
17.
go back to reference Besbas N, Saatci U, Ruacan S, Ozen S, Sungur A, Bakkaloglu A, Elnahas AM (1997) The role of cytokines in Henoch–Schonlein purpura. Scand J Rheumatol 26:456–460CrossRefPubMed Besbas N, Saatci U, Ruacan S, Ozen S, Sungur A, Bakkaloglu A, Elnahas AM (1997) The role of cytokines in Henoch–Schonlein purpura. Scand J Rheumatol 26:456–460CrossRefPubMed
18.
go back to reference Ha TS (2005) The role of tumor necrosis factor-alpha in Henoch–Schonlein purpura. Pediatr Nephrol 20:149–153CrossRefPubMed Ha TS (2005) The role of tumor necrosis factor-alpha in Henoch–Schonlein purpura. Pediatr Nephrol 20:149–153CrossRefPubMed
19.
20.
go back to reference Menges T, Engel J, Welters I, Wagner RM, Little S, Ruwoldt R, Wollbrueck M, Hempelmann G (1999) Changes in blood lymphocyte populations after multiple trauma. Crit Care Med 27:733–740CrossRefPubMed Menges T, Engel J, Welters I, Wagner RM, Little S, Ruwoldt R, Wollbrueck M, Hempelmann G (1999) Changes in blood lymphocyte populations after multiple trauma. Crit Care Med 27:733–740CrossRefPubMed
21.
go back to reference Hotchkiss RS, Swanson PE, Freeman BD, Tinsley KW, Cobb JP, Matuschak GM, Buchman TG, Karl IE (1999) Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med 27:1230–1251CrossRefPubMed Hotchkiss RS, Swanson PE, Freeman BD, Tinsley KW, Cobb JP, Matuschak GM, Buchman TG, Karl IE (1999) Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med 27:1230–1251CrossRefPubMed
22.
go back to reference Ronkainen J, Koskimies O, Ala-Houhala M, Antikainen M, Merenmies J, Rajantie J, Ormälä T, Turtinen J, Nuutinen M (2006) Early prednisone therapy in Henoch–Schönlein purpura: a randomized, double-blind, placebo-controlled trial. J Pediatr 149:241–247CrossRefPubMed Ronkainen J, Koskimies O, Ala-Houhala M, Antikainen M, Merenmies J, Rajantie J, Ormälä T, Turtinen J, Nuutinen M (2006) Early prednisone therapy in Henoch–Schönlein purpura: a randomized, double-blind, placebo-controlled trial. J Pediatr 149:241–247CrossRefPubMed
23.
go back to reference Weiss PF, Klink AJ, Localio R, Hall M, Hexem K, Burnham JM, Keren R, Feudtner C (2010) Corticosteroids may improve clinical outcomes during hospitalization for Henoch–Schönlein purpura. Pediatrics 126:674–681CrossRefPubMedPubMedCentral Weiss PF, Klink AJ, Localio R, Hall M, Hexem K, Burnham JM, Keren R, Feudtner C (2010) Corticosteroids may improve clinical outcomes during hospitalization for Henoch–Schönlein purpura. Pediatrics 126:674–681CrossRefPubMedPubMedCentral
24.
go back to reference Chartapisak W, Opastirakul S, Hodson E, Willis N, Craig J (2009) Interventions for preventing and treating kidney disease in Henoch–Schönlein purpura (HSP). Cochrane Datab Syst Rev 2009:005128 Chartapisak W, Opastirakul S, Hodson E, Willis N, Craig J (2009) Interventions for preventing and treating kidney disease in Henoch–Schönlein purpura (HSP). Cochrane Datab Syst Rev 2009:005128
25.
go back to reference Jauhola O, Ronkainen J, Koskimies O, Ala-Houhala M, Arikoski P, Hölttä T, Jahnukainen T, Rajantie J, Örmälä T, Nuutinen M (2012) Outcome of Henoch–Schönlein purpura 8 years after treatment with a placebo or prednisone at disease onset. Pediatr Nephrol 27:933–999CrossRefPubMed Jauhola O, Ronkainen J, Koskimies O, Ala-Houhala M, Arikoski P, Hölttä T, Jahnukainen T, Rajantie J, Örmälä T, Nuutinen M (2012) Outcome of Henoch–Schönlein purpura 8 years after treatment with a placebo or prednisone at disease onset. Pediatr Nephrol 27:933–999CrossRefPubMed
Metadata
Title
The relationship of neutrophil-to-lymphocyte ratio with gastrointestinal bleeding in Henoch–Schonlein purpura
Authors
Balahan Makay
Özge Altuğ Gücenmez
Murat Duman
Erbil Ünsal
Publication date
01-09-2014
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 9/2014
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-014-2986-2

Other articles of this Issue 9/2014

Rheumatology International 9/2014 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.